Our Pricing

Aciclovir vs Valaciclovir for Cold Sores UK

Published on: June 03, 2026

When comparing aciclovir vs valaciclovir for cold sores UK treatments, understanding the key differences in dosing frequency, bioavailability, and clinical outcomes helps you choose the most suitable antiviral medication. Both are MHRA-licensed treatments that target the herpes simplex virus (HSV-1), but they differ significantly in how your body processes them and how often you need to take doses.

How Aciclovir and Valaciclovir Work Against Cold Sores

Aciclovir is a nucleoside analogue antiviral that works by inhibiting viral DNA polymerase, preventing the herpes simplex virus from replicating in infected cells [1]. When applied topically as a cream or taken orally as tablets, aciclovir targets active viral replication during a cold sore outbreak, reducing the duration and severity of symptoms.

Valaciclovir is actually a prodrug of aciclovir — meaning your body converts it into aciclovir after absorption [2]. The critical difference lies in bioavailability: valaciclovir achieves approximately 54% oral bioavailability compared to just 15-20% for standard aciclovir tablets [2]. This superior absorption allows valaciclovir to deliver higher concentrations of active antiviral medication with fewer daily doses.

Both medications require viral thymidine kinase to become active, which is why they selectively target infected cells whilst leaving healthy tissue largely unaffected [1]. This targeted mechanism explains why side effects remain minimal for most patients using either treatment.

Aciclovir vs Valaciclovir: Dosing and Convenience

The most significant practical difference between aciclovir and valaciclovir for cold sores is dosing frequency. Standard aciclovir tablets for cold sore treatment typically require five doses daily (200mg five times per day) for five days, which many patients find difficult to maintain consistently [3].

Valaciclovir offers considerably more convenient dosing: most UK prescribers recommend 2000mg twice daily for one day only, or alternatively 500mg twice daily for three to five days [3]. This simplified regimen improves treatment adherence and makes valaciclovir particularly suitable for patients with busy schedules or those who struggle with frequent dosing.

Aciclovir cream (5% formulation) requires application five times daily to the affected area, ideally at the first sign of tingling or prodromal symptoms [4]. Whilst topical treatment avoids systemic absorption, clinical evidence suggests oral antivirals generally produce superior outcomes compared to topical formulations for recurrent cold sores [4].

Which Dosing Schedule Suits Your Lifestyle?

If you experience frequent cold sore outbreaks and prefer keeping treatment at home for immediate use, aciclovir cream offers a non-prescription option available from £4.49 at Cured Pharmacy. For patients seeking more potent systemic treatment with minimal dosing interruption, valaciclovir tablets provide a prescription-only alternative that requires clinical assessment by a UK prescriber before dispensing.

Clinical Efficacy: Aciclovir vs Valaciclovir for Cold Sores

Clinical trials demonstrate that both aciclovir and valaciclovir significantly reduce cold sore healing time when initiated during the prodromal phase or within 24 hours of lesion appearance [3][5]. A pivotal study comparing single-day valaciclovir treatment (2000mg twice daily for one day) against placebo showed a reduction in episode duration by approximately one day on average [5].

Oral aciclovir tablets at standard dosing (200mg five times daily for five days) similarly reduce healing time by approximately one to two days compared to untreated outbreaks [3]. The clinical outcomes between properly dosed aciclovir and valaciclovir are comparable because valaciclovir converts to aciclovir in the body — the key advantage of valaciclovir lies in achieving therapeutic drug levels with fewer doses rather than superior antiviral potency.

Topical aciclovir cream demonstrates more modest benefits, typically shortening healing time by less than one day in clinical trials [4]. Systemic absorption from topical application remains minimal, which limits its effectiveness compared to oral formulations for moderate to severe recurrent cold sores.

When to Start Treatment for Best Results

Both aciclovir and valaciclovir work most effectively when started at the earliest sign of a cold sore — typically during the tingling or itching prodromal stage before visible blisters appear [5]. Patients who keep treatment readily available and initiate therapy immediately upon recognising prodromal symptoms achieve the greatest reduction in outbreak duration and severity.

Side Effects and Safety Profile Comparison

Both aciclovir and valaciclovir are generally well-tolerated antiviral medications with similar safety profiles, as valaciclovir converts to aciclovir after absorption [2]. The most commonly reported side effects include headache, nausea, and gastrointestinal discomfort, occurring in fewer than 10% of patients taking oral formulations [6].

Topical aciclovir cream may cause localised skin reactions including mild burning, stinging, or dryness at the application site in some users [4]. These reactions are typically transient and resolve without requiring treatment discontinuation.

Serious adverse effects remain rare with both medications when used at recommended doses for cold sore treatment. Patients with renal impairment require dose adjustments for oral aciclovir and valaciclovir, as both drugs are primarily eliminated through the kidneys [6]. Your UK prescriber will assess your medical history during the online consultation to ensure safe prescribing.

Cost Considerations: Aciclovir vs Valaciclovir UK Pricing

Aciclovir cold sore treatments are available at competitive UK pricing, with topical cream formulations offering the most accessible entry point for patients seeking non-prescription relief. At Cured Pharmacy, Numark Cold Sore Cream containing 5% aciclovir starts from £4.49, providing an affordable option for mild to moderate outbreaks.

Prescription aciclovir tablets and valaciclovir require clinical assessment by a UK prescriber before dispensing, with final costs varying based on prescribed strength and treatment duration. Valaciclovir typically costs more per course than standard aciclovir tablets, though the convenience of reduced dosing frequency and single-day treatment options often justifies the price difference for patients prioritising adherence and lifestyle compatibility.

When comparing overall value, consider both the upfront medication cost and the practical benefits of treatment adherence. A more expensive medication that you actually complete as prescribed delivers better clinical outcomes than a cheaper alternative with a complex dosing schedule you struggle to follow consistently.

Transparent Pricing at Cured Pharmacy

Unlike many UK online pharmacies, Cured Pharmacy displays transparent upfront pricing before you complete your clinical consultation. You'll see exactly what you'll pay for aciclovir treatments, with no hidden fees or surprise costs at checkout. All prescription medications require approval from our UK-registered prescribers following a free online assessment that takes under three minutes to complete.

Choosing Between Aciclovir and Valaciclovir: Clinical Guidance

For patients experiencing their first cold sore outbreak or those with infrequent mild episodes, topical aciclovir cream often provides sufficient relief without requiring prescription approval. The 5% cream formulation works best when applied at the earliest sign of symptoms and continued five times daily until the lesion heals completely.

Valaciclovir represents the preferred choice for patients with frequent recurrent outbreaks (six or more episodes per year), those who struggle with complex dosing schedules, or individuals seeking the most convenient single-day treatment option [3][5]. The superior bioavailability and simplified dosing make valaciclovir particularly suitable for suppressive therapy in patients with very frequent recurrences, though this requires ongoing prescriber supervision.

Standard oral aciclovir tablets offer a middle-ground option: more potent than topical cream but requiring more frequent daily dosing than valaciclovir. Some patients prefer aciclovir tablets for episodic treatment when they can manage the five-times-daily schedule, particularly if cost considerations are paramount.

Personalised Treatment Selection

During your free online consultation at Cured Pharmacy, our UK-registered prescribers assess your cold sore history, outbreak frequency, previous treatment responses, and lifestyle factors to recommend the most appropriate antiviral option. Factors including your work schedule, ability to adhere to frequent dosing, and severity of typical outbreaks all influence which medication offers optimal outcomes for your individual circumstances.

Scientific References

1. Elion, G. B., Furman, P. A., Fyfe, J. A., de Miranda, P., Beauchamp, L., & Schaeffer, H. J. (1977). Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proceedings of the National Academy of Sciences, 74(12), 5716–5720. https://doi.org/10.1073/pnas.74.12.5716 [accessed 13 August 2026]
2. Soul-Lawton, J., Seaber, E., On, N., Wootton, R., Rolan, P., & Posner, J. (1995). Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrobial Agents and Chemotherapy, 39(12), 2759–2764. https://doi.org/10.1128/AAC.39.12.2759 [accessed 13 August 2026]
3. Spruance, S. L., Jones, T. M., Blatter, M. M., Vargas-Cortes, M., Barber, J., Hill, J., Goldstein, D., & Schultz, M. (2003). High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Antimicrobial Agents and Chemotherapy, 47(3), 1072–1080. https://doi.org/10.1128/AAC.47.3.1072-1080.2003 [accessed 13 August 2026]
4. Spruance, S. L., Nett, R., Marbury, T., Wolff, R., Johnson, J., & Spaulding, T. (2002). Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrobial Agents and Chemotherapy, 46(7), 2238–2243. https://doi.org/10.1128/AAC.46.7.2238-2243.2002 [accessed 13 August 2026]
5. Spruance, S. L., Bodsworth, N., Resnick, H., Conant, M., Oeuvray, C., Gao, J., & Boon, R. (2006). Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. Journal of the American Academy of Dermatology, 55(1), 47–53. https://doi.org/10.1016/j.jaad.2006.02.031 [accessed 13 August 2026]
6. Patel, R., & Bodsworth, N. J. (2000). Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. Genitourinary Medicine, 73(2), 105–109. https://doi.org/10.1136/sti.73.2.105 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.